University of Navarra (Spain) researchers have developed RNACOREX, a new open-source software capable of identifying gene regulation networks with applications in cancer survival analysis.

Spanish researchers have created a powerful new open-source tool that helps uncover the hidden genetic networks driving ...

While the production world of feature filmmaking has cutting-edge technology and long-standing systems in place, the world of ...

The digital health revolution is accelerating at an unprecedented pace, transforming how we diagnose diseases, deliver care, and manage wellness. From AI-powere ...

GE HealthCare and Tribun Health collaboration helps foster enterprise imaging and pathology for oncology CHICAGO, ILLINOIS / ACCESS Newswire / / GE HealthCare (Nasdaq: GEHC) announced today that Sant ...

Studies across all breast-cancer subtypes confirm Pathlight’s ultra-sensitive performance for early recurrence detection and treatment-response monitoring "Building on the very compelling TRACER data, ...

Studies across all breast-cancer subtypes confirm Pathlight’s ultra-sensitive performance for early recurrence detection and treatment-response monitoring MORRISVILLE, N.C.--(BUSINESS ...

This image of South Maui comes from the updated State of Hawaii Sea Level Rise Viewer. The viewer is meant to help Hawaii residents, planners and officials better understand how their communities ...

Artificial intelligence is transforming the everyday practice of medicine — from simplifying diagnostic workflows to helping clinicians make faster, more informed decisions. To explore how AI can ...

STOW, Ohio--(BUSINESS WIRE)--Matco Tools, a franchisee-led brand delivering quality automotive tools to professional technicians, is proud to announce the nationwide rollout of the Eagle Experience, a ...

Not being able to turn off Send optional diagnostic data settings undermines our privacy and control and can be really frustrating. This issue often occurs when system policies, background services, ...

Quest Diagnostics is launching a new pharmacogenomics program designed to decode patients’ DNA to predict how they will respond to certain therapies and doses. The company said its test will span ...